Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo
The peptide hormone GLP-1 has the potential to be a remedy for diabetes type II, yet is unstable. Here, the authors synthesized α-peptide-oligourea hybrid analogues of GLP-1 some of which showing significantly prolonged activity in vivo.
Guardado en:
Autores principales: | Juliette Fremaux, Claire Venin, Laura Mauran, Robert H. Zimmer, Gilles Guichard, Sébastien R. Goudreau |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7e2c09e5f5e9452e9f698d011ed0817b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analogue modulation of back-propagating action potentials enables dendritic hybrid signalling
por: János Brunner, et al.
Publicado: (2016) -
GLP-1 Induces the Expression of FNDC5 Derivatives That Execute Lipolytic Actions
por: Hui Li, et al.
Publicado: (2021) -
IMMUNOMODULATORY ACTIVITY OF ANTIMICROBIAL PEPTIDE INDOLICIDIN AND ITS STRUCTURAL ANALOGUES
por: A. Yu. Artamonov, et al.
Publicado: (2014) -
Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic review.
por: Martin C S Wong, et al.
Publicado: (2014) -
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity.
por: Paolo Grieco, et al.
Publicado: (2013)